VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246 | -34.6% | 57 | 0.0% | 0.00% | – |
| Q2 2023 | $376 | -2.8% | 57 | 0.0% | 0.00% | – |
| Q1 2023 | $387 | -8.1% | 57 | 0.0% | 0.00% | – |
| Q4 2022 | $421 | -57.9% | 57 | -32.9% | 0.00% | – |
| Q3 2022 | $1,000 | -99.9% | 85 | -99.9% | 0.00% | -100.0% |
| Q2 2022 | $804,000 | +21.8% | 73,767 | +26.4% | 0.00% | +33.3% |
| Q1 2022 | $660,000 | -4.5% | 58,367 | +32.6% | 0.00% | 0.0% |
| Q4 2021 | $691,000 | -13.8% | 44,010 | -5.9% | 0.00% | -25.0% |
| Q3 2021 | $802,000 | -12.9% | 46,766 | +9.2% | 0.00% | 0.0% |
| Q2 2021 | $921,000 | +63.9% | 42,817 | +14.4% | 0.00% | +33.3% |
| Q1 2021 | $562,000 | +49.1% | 37,425 | +30.4% | 0.00% | +50.0% |
| Q4 2020 | $377,000 | +62.5% | 28,703 | +19.3% | 0.00% | +100.0% |
| Q3 2020 | $232,000 | +64.5% | 24,059 | +95.5% | 0.00% | 0.0% |
| Q2 2020 | $141,000 | – | 12,307 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |